| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.8 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.8. The average price that BIM.PA shares were previous bought at was EUR 108.326. The current market price is 9.7% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 77,212 (USD $87,556) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 44.5 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 44.5. The average price that FME.DE shares were previous bought at was EUR 44.4066. The current market price is 0.2% higher than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 90,312 (USD $102,411) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 59.6103 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 59.6103. The average price that ZEAL.CO shares were previous bought at was DKK 83.2446. The current market price is -28.4% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 27,410 (USD $4,164) compared to the previous valuation of |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 50.72 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 50.72. The average price that ERF.PA shares were previous bought at was EUR 48.9498. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 62,295 (USD $70,640) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 194.15 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 194.15. The average price that SRT3.DE shares were previous bought at was EUR 222.106. The current market price is -12.6% lower than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 48,102 (USD $54,546) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 23.9675 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 23.9675. The average price that SOBI.ST shares were previous bought at was SEK 26.9845. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 22,261 (USD $2,278) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 86.0632 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 86.0632. The average price that GALD.SW shares were previous bought at was CHF 97.2295. The current market price is -11.5% lower than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 65,830 (USD $80,678) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 172.9 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 172.9. The average price that DIM.PA shares were previous bought at was EUR 187.348. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 39,939 (USD $45,290) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.36 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.36. The average price that REC.MI shares were previous bought at was EUR 52.7232. The current market price is -8.3% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 39,238 (USD $44,495) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 49.92 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 49.92. The average price that ORNBV.HE shares were previous bought at was EUR 47.9229. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 36,732 (USD $41,653) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 291.772 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 291.772. The average price that RO.SW shares were previous bought at was CHF 305.639. The current market price is -4.5% lower than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 82,098 (USD $100,615) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 99.15 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 99.15. The average price that IPN.PA shares were previous bought at was EUR 109.524. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 31,287 (USD $35,478) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 22.298 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 22.298. The average price that HIK.L shares were previous bought at was GBP 24.5528. The current market price is -9.2% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 48,543 (USD $63,953) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 30.4615 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 30.4615. The average price that DEMANT.CO shares were previous bought at was DKK 34.6261. The current market price is -12.0% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 13,783 (USD $2,094) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.316 | EUR 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 16.75 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 16.75. The average price that AMP.MI shares were previous bought at was EUR 23.5373. The current market price is -28.8% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 48,133 (USD $54,581) compared to the previous valuation of Amplifon SpA |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 57.0183 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 57.0183. The average price that NOVO-B.CO shares were previous bought at was DKK 72.6601. The current market price is -21.5% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 2,054,755 (USD $312,167) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 94.0637 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 94.0637. The average price that COLO-B.CO shares were previous bought at was DKK 99.4698. The current market price is -5.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 62,970 (USD $9,567) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 37.175 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 37.175. The average price that QIA.DE shares were previous bought at was EUR 36.5498. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in QIA.DE has increased by EUR 4,077 (USD $4,623) compared to the previous valuation of QIAGEN NV however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.42569 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.42569. The average price that HLN.L shares were previous bought at was GBP 4.68254. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 123,717 (USD $162,991) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 20.825 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 20.825. The average price that BAYN.DE shares were previous bought at was EUR 21.037. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 30,033 (USD $34,056) compared to the previous valuation of Bayer AG |
| NOVN.SW - | HOLD | 0 @ CHF 97.4015 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 97.4015. The average price that NOVN.SW shares were previous bought at was CHF 97.8035. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 1,753,748 (USD $2,149,306) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 120.201 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 120.201. The average price that AZN.L shares were previous bought at was GBP 130.736. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 351,993 (USD $463,734) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 91.62 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 91.62. The average price that SAN.PA shares were previous bought at was EUR 97.8777. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 139,004 (USD $157,626) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 15.7384 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 15.7384. The average price that GSK.L shares were previous bought at was GBP 16.7685. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 773,084 (USD $1,018,502) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 251.2 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 251.2. The average price that EL.PA shares were previous bought at was EUR 249.655. The current market price is 0.6% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 573,426 (USD $650,246) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 583.761 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 583.761. The average price that LONN.SW shares were previous bought at was CHF 574.681. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 387,203 (USD $474,537) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 81.3767 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 81.3767. The average price that ALC.SW shares were previous bought at was CHF 82.745. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 376,594 (USD $461,535) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 530 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 530. The average price that ARGX.BR shares were previous bought at was EUR 575.954. The current market price is -8.0% lower than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 73,837 (USD $83,729) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 142.5 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 142.5. The average price that UCB.BR shares were previous bought at was EUR 179.631. The current market price is -20.7% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 202,205 (USD $229,294) compared to the previous valuation of UCB SA however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 275.791 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 275.791. The average price that ROG.SW shares were previous bought at was CHF 289.065. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,615,844 (USD $1,980,298) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 21.25 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 21.25. The average price that PHIA.AS shares were previous bought at was EUR 24.2436. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 82,661 (USD $93,735) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 118.95 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 118.95. The average price that MRK.DE shares were previous bought at was EUR 136.276. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 85,079 (USD $96,477) compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 36.099 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 36.099. The average price that SDZ.SW shares were previous bought at was CHF 39.7514. The current market price is -9.2% lower than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 171,481 (USD $210,159) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 252.682 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 252.682. The average price that SOON.SW shares were previous bought at was CHF 301.597. The current market price is -16.2% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 21,228 (USD $26,016) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 44.83 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 44.83. The average price that SHL.DE shares were previous bought at was EUR 51.351. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 69,922 (USD $79,289) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 39.12 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 39.12. The average price that FRE.DE shares were previous bought at was EUR 35.7153. The current market price is 9.5% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 176,821 (USD $200,509) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 173.205 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 173.205. The average price that GMAB.CO shares were previous bought at was DKK 195.655. The current market price is -11.5% lower than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 76,282 (USD $11,589) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 106.04 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 106.04. The average price that STMN.SW shares were previous bought at was CHF 120.847. The current market price is -12.3% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 81,662 (USD $100,081) compared to the previous valuation of however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 11.6132 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 11.6132. The average price that SN.L shares were previous bought at was GBP 12.9824. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in SN.L has increased by GBP 36,717 (USD $48,373) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-04-15 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | SELL | -840 @ EUR 97.16 | EUR -81,614 | The ETF sold 840 shares of DIA.MI on 2025-04-15. The shares were previously bought for an average price of EUR 99.7953. The DiaSorin SpA shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,214 (USD $2,510) The average price that the ETF previously sold DIA.MI share for is EUR 99.7293 which is higher than the selling price of EUR 97.16 on 2025-04-15. |